Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

After losing her son, DeVon, to Type 1 diabetes complications at 33, Cathy Staton is raising awareness and offering ...

First new drug in 30 years to slow kidney disease in type 1 diabetes ...

Obviously caveats must be drawn from a mouse model such as this, but the results have supercharged the team's determination.

Lantidra therapy infuses healthy islet cells into patients' livers, with some achieving insulin independence. University ...

Explore the breakthrough therapy that offers hope to cure type 1 diabetes by restoring insulin-producing beta cells ...

Supporting emotional well being is just as important as adjusting insulin doses.”— Dr. Erin Roe DALLAS, TX, UNITED ...

While it has long been known that type 1 diabetes runs in families, experts are less certain about what actually starts the autoimmune attack that defines the disease. Most people with type 1 diabetes ...

Diabetes is a chronic health condition that impairs the body's ability to use or produce insulin, a hormone that regulates the conversion of sugar from food into energy, resulting in dangerously ...

Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...

An “immune system reset” eliminated autoimmune, or Type 1, diabetes in mice in a study conducted at. Researchers say the strategy could also have potential for treating other autoimmune diseases and ...